GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Total Assets

CBIH (Cannabis Bioscience International Holdings) Total Assets : $0.04 Mil (As of Nov. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Total Assets?

Cannabis Bioscience International Holdings's Total Assets for the quarter that ended in Nov. 2024 was $0.04 Mil.

During the past 12 months, Cannabis Bioscience International Holdings's average Total Assets Growth Rate was -66.70% per year. During the past 3 years, the average Total Assets Growth Rate was -90.70% per year.

During the past 7 years, Cannabis Bioscience International Holdings's highest 3-Year average Total Assets Growth Rate was 1887.10%. The lowest was -90.70%. And the median was -90.00%.

Total Assets is connected with ROA %. Cannabis Bioscience International Holdings's annualized ROA % for the quarter that ended in Nov. 2024 was -790.12%. Total Assets is also linked to Revenue through Asset Turnover. Cannabis Bioscience International Holdings's Asset Turnover for the quarter that ended in Nov. 2024 was 1.83.


Cannabis Bioscience International Holdings Total Assets Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Total Assets Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24
Total Assets
Get a 7-Day Free Trial 34.84 71.71 93.04 0.04 0.06

Cannabis Bioscience International Holdings Quarterly Data
Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.09 0.06 0.05 0.04

Cannabis Bioscience International Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cannabis Bioscience International Holdings's Total Assets for the fiscal year that ended in May. 2024 is calculated as

Total Assets=Total Equity (A: May. 2024 )+Total Liabilities (A: May. 2024 )
=-1.079+1.136
=0.06

Cannabis Bioscience International Holdings's Total Assets for the quarter that ended in Nov. 2024 is calculated as

Total Assets=Total Equity (Q: Nov. 2024 )+Total Liabilities (Q: Nov. 2024 )
=-1.165+1.2
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Total Assets Explanation

Total Assets is connected with ROA %.

Cannabis Bioscience International Holdings's annualized ROA % for the quarter that ended in Nov. 2024 is

ROA %=Net Income (Q: Nov. 2024 )/( (Total Assets (Q: Aug. 2024 )+Total Assets (Q: Nov. 2024 ))/ count )
=-0.32/( (0.046+0.035)/ 2 )
=-0.32/0.0405
=-790.12 %

Note: The Net Income data used here is four times the quarterly (Nov. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cannabis Bioscience International Holdings's Asset Turnover for the quarter that ended in Nov. 2024 is

Asset Turnover
=Revenue (Q: Nov. 2024 )/( (Total Assets (Q: Aug. 2024 )+Total Assets (Q: Nov. 2024 ))/ count )
=0.074/( (0.046+0.035)/ 2 )
=0.074/0.0405
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cannabis Bioscience International Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.